Skip to main content

BGF World Healthscience Fund

BGF World Healthscience Fund is an equity fund managed by BlackRock in the Sektor – Helse category.

About this fund

Categorised as Sektor – Helse, BGF World Healthscience Fund is an equity fund from BlackRock.

The fund dates from 2001, giving it 25 years of history.

It ranks 8 out of 18 in its peer group on return so far this year measured in NOK as of 13.11.2026.

It is run by a team of 2.

The manager states a volatility of 12.5% for the fund.

The reference index is MSCI WRLD HealthCare ND (USD).

Manager
BlackRock
Category
Sektor – Helse
Region
Global
Sector
Health Care
Style
Sector Focus
SFDR
Article 8
ISIN
LU0122379950
Inception
2001-04-06
Benchmark
MSCI WRLD HealthCare ND (USD)
AUM
13.1 bn USD
Returns
YTD 9.5% · 1Y 12.5% · 3Y 7.5% · 5Y 7.8%

Portfolio managers

Actively managedEquityGlobalHealth care
YTD Return · NOK
+9,5 %from NAV
Calculated NOK return from USD · A2 (USD) (NOK Calculated)

Computed from NAV history (total return, NOK, to 16 Nov 2026)

Last NAV 86,26 USD · 16 Nov 2026
Returns by period · NOK · net
ann. 3Y+
+9,5 %
YTD
+12,5 %
1y
+7,5 %
3y, annualised
+7,8 %
5y, annualised
Fund size
13,1 mrd. USD
Total fund AUM
Management fee
1,50 %
Annual · class A2
Ongoing charge
1,81 %
Annual · class A2
Performance fee
None
Stated by the manager
Annual cost on platforms
1,16 %–1,29 %
Class A2 · 5 platforms · net of platform rebate, incl. platform fee, excl. transaction costs
SFDR
Article 8
Sustainability
Launched
Apr 2001
ISIN LU0122379950
BenchmarkMSCI WRLD HealthCare ND (USD)
Fund website
Risk
Volatility (stated by the manager)12,5 %
Beta0,91
About the fund
The fund

BGF World Healthscience Fund is an actively managed global health care equity fund with history back to 2001. It is managed by BlackRock, the world's largest asset manager, headquartered in New York. The company is publicly listed with dispersed ownership and covers both index funds and active strategies.

Investment philosophy

The mandate requires at least 70% of the fund's assets to be invested in equities of companies whose main business is in health care, pharmaceuticals, medical technology and supplies, or the development of biotechnology. The fund follows BlackRock's ESG policy as described in the prospectus.

The managers

The fund is managed by BlackRock's Health Sciences team in Boston. Erin Xie leads the team and has managed the fund since 2011. She holds a PhD in biochemistry from UCLA and an MBA from MIT Sloan, and has a background from State Street Research. Xiang Liu has been co-manager since 2020 and has been at BlackRock since 2008. He holds a PhD from Yale and an MBA from Chicago, with a background in business development at Cubist and health care consulting at Boston Consulting Group. Both also manage BGF Next Generation Health Care Fund.

The portfolio

The portfolio is broad, with many more positions than comparable funds, and consists mainly of large companies. Pharmaceuticals and biotechnology are lasting centres of gravity. Companies such as Johnson & Johnson, Eli Lilly, AbbVie and Novartis recur among the larger positions. The fund has fluctuated less than comparable funds.

FundTelligence description · 18/10/2026
Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

Portfolio managers

ER
Portfolio Manager
On the fund since Apr 1, 2011
XI
Portfolio Manager
On the fund since Jun 1, 2020

Position in the peer group

Sector Health Care Equities · 31 funds in the peer group. The number ranked and the date are stated per period. 12 of them converted to NOK.

7 of 18 funds ranked on a calculated return

#8/ 18Year to date
+9.54% NOK
From NAV as of 16 Nov 2026

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

13 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#10/ 221 year
+12.48% NOK
From NAV as of 16 Nov 2026

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#13/ 223 years (ann.)
+7.48% NOK
From NAV as of 16 Nov 2026

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

#6/ 225 years (ann.)
+7.85% NOK
From NAV as of 16 Nov 2026

as of 13 Nov 2026 · Converted from USD to NOK

About the figures

9 of 31 funds in the group hold no figure for the date and are not counted. 1 funds with older figures: up to 5 business days.

Comparison basis

Year to date

Comparison basis: Ranked among 18 of 31 funds · 13 left out (5 share class outside the rule, 3 missing return, 1 return as of an earlier date, 1 history too short, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

1 year

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

3 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

5 years (ann.)

Comparison basis: Ranked among 22 of 31 funds · 9 left out (4 missing return, 2 return as of an earlier date, 3 return without a stated date) · returns as of 12 Nov 2026–13 Nov 2026

The positions describe historical return and are not an assessment of the fund, nor investment advice. Past performance is no guarantee of future returns. A position applies only within its own peer group and cannot be compared with positions in other peer groups.

Fund data is taken from the managers’ own reports, otherwise computed from NAV history and, as a last resort, taken from distributor listings. Not official figures; verify with the fund provider before investing.

About our data